| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Neurocrine Biosciences, Inc. (NBIX) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. NBIX is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 140.4K | $23.05M | - | |
| Other | 52.8K | $8.66M | - | |
| Other | 46.8K | $7.68M | - | |
| Other | 39.6K | $6.51M | -36,937 | |
| Other | 36.8K | $6.05M | -11,000 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 6, 2017 | Gorman Kevin Charles55 | Chief Executive Officer | Sale+OE | 3,010 | $43.18 | $129,971.80 | -1.2% | |
| Feb 3, 2017 | Bozigian Haig P. | Chief Development Officer | Sell | 1,375 | $42.57 | $58,533.75 | -1.2% | |
| Feb 3, 2017 | Coughlin Timothy P75 | Chief Financial Officer | Sell | 1,500 | $42.55 | $63,825.00 | -1.1% | |
| Feb 3, 2017 | Gano Kyle54 | Chief Business Development Off | Sell | 1,375 | $42.57 | $58,533.75 | -2.2% | |
| Feb 3, 2017 | Gorman Kevin Charles55 | Chief Executive Officer | Sell | 3,125 | $42.55 | $132,968.75 | -1.2% | |
| Feb 3, 2017 | Grigoriadis Dimitri E. | Chief Research Officer | Sell | 1,375 | $42.56 | $58,520.00 | -1.2% | |
| Feb 3, 2017 | Obrien Christopher Flint | Chief Medical Officer | Sell | 1,500 | $42.50 | $63,750.00 | -4.1% | |
| Feb 1, 2017 | Rastetter William H48 | Director | Sale+OE | 10,750 | $42.28 | $454,510.00 | -43.0% | |
| Jan 17, 2017 | Bozigian Haig P. | Chief Development Officer | Sell | 1,625 | $40.63 | $66,023.75 | -1.4% | |
| Jan 17, 2017 | Coughlin Timothy P75 | Chief Financial Officer | Sell | 1,750 | $40.65 | $71,137.50 | -1.3% |